Distinction Between Lung Cancer and Gynecological Cancers by Canine Scent Detection
NCT ID: NCT01383408
Last Updated: 2013-05-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
752 participants
INTERVENTIONAL
2011-03-31
2013-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Detection of Lung Tumors by Sniffer Dogs - Evaluation of Sensitivity and Specificity
NCT01141842
Identifying Unique Scent Signature of Lung Cancer Through Body Odor
NCT01527461
Canine-Assisted Profiling of Lung Cancer From Human Breath
NCT02759679
Breath Analysis to Diagnose Lung Cancer
NCT03250390
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
NCT02049658
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy individual
healthy individual with no lung disease and no history of cancer including lung cancer
exhalation analysis of breath sample
study participants exhale 5 times into a test tube; test tube is presented to sniffer dogs for analysis
lung cancer
patients with histologically confirmed lung cancer, but no history of other cancer
exhalation analysis of breath sample
study participants exhale 5 times into a test tube; test tube is presented to sniffer dogs for analysis
breast cancer
patients with histologically confirmed breast cancer, but no history of other cancer
exhalation analysis of breath sample
study participants exhale 5 times into a test tube; test tube is presented to sniffer dogs for analysis
ovarian cancer
patients with histologically confirmed ovarian cancer, but no history of other cancer
exhalation analysis of breath sample
study participants exhale 5 times into a test tube; test tube is presented to sniffer dogs for analysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
exhalation analysis of breath sample
study participants exhale 5 times into a test tube; test tube is presented to sniffer dogs for analysis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* previous medical intervention within the last 14 days before gathering of the breath sample
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
OTHER
Schillerhoehe Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thorsten Walles
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thorsten Walles, MD
Role: PRINCIPAL_INVESTIGATOR
Schillerhoehe Hospital
Godehard Friedel, MD
Role: STUDY_CHAIR
Schillerhoehe Hospital
Wolfgang Simon, MD
Role: STUDY_CHAIR
Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Schillerhoehe Hospital
Gerlingen, Baden-Wurttemberg, Germany
Robert Bosch Hospital
Stuttgart, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Boedeker E, Friedel G, Walles T. Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg. 2012 May;14(5):511-5. doi: 10.1093/icvts/ivr070. Epub 2012 Feb 17.
Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSH-TCH-IIT-2011-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.